Products for Research Use Only
RegisterLogin

Selitrectinib

CAT: 0804-HY-101977-04Size: 25 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-101977-04Size:25 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Selitrectinib (LOXO-195) is a next-generation TRK kinase inhibitor, with IC50s of 0.6 nM and TRKA and TRKC, respectively[1].
CAS Number
2097002-61-2
Product Name Alternative
LOXO-195
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Trk Receptor
Type
Reference compound
Related Pathways
Neuronal Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/LOXO-195.html
Concentration
10mM
Purity
99.90
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
FC1=CN=C(CC[C@H](N2)C)C([C@](CCC3)([H])N3C(C=CN4N=C5)=NC4=C5C2=O)=C1
Molecular Formula
C20H21FN6O
Molecular Weight
380.42
Precautions
H302, H315, H319, H335
References & Citations
[1]Drilon A, et al. A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid Tumors. Cancer Discov. 2017 Sep;7 (9) :963-972.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
TrkA; TrkC

Chemical Information

Selitrectinib

Selitrectinib is under investigation in clinical trial NCT03215511 (Phase 1/2 Study of LOXO-195 in Patients With Previously Treated NTRK Fusion Cancers).

CAS Number2097002-61-2
PubChem CID129103609
IUPAC Name(6R,15R)-9-fluoro-15-methyl-2,11,16,20,21,24-hexazapentacyclo[16.5.2.02,6.07,12.021,25]pentacosa-1(24),7(12),8,10,18(25),19,22-heptaen-17-one
Molecular FormulaC20H21FN6O
Molecular Weight380.4
XLogP2
Topological Polar Surface Area75.4
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count0
Heavy Atom Count28
Formal Charge0
Complexity593
SMILES
C[C@@H]1CCC2=C(C=C(C=N2)F)[C@H]3CCCN3C4=NC5=C(C=NN5C=C4)C(=O)N1
InChI
InChI=1S/C20H21FN6O/c1-12-4-5-16-14(9-13(21)10-22-16)17-3-2-7-26(17)18-6-8-27-19(25-18)15(11-23-27)20(28)24-12/h6,8-12,17H,2-5,7H2,1H3,(H,24,28)/t12-,17-/m1/s1
InChIKey
OEBIHOVSAMBXIB-SJKOYZFVSA-N
Chemical Structure
2D Structure
2D structure of Selitrectinib
CAS: 2097002-61-2
CID: 129103609
Formula: C20H21FN6O
MW: 380.4
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight380.4
XLogP32
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count0
Exact Mass380.17608748
Monoisotopic Mass380.17608748
Topological Polar Surface Area75.4 Ų
Heavy Atom Count28
Formal Charge0
Complexity593
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Alternative Products

CatalogName
MBS5758331Selitrectinib
A19252-100Selitrectinib 100mg
M28716-01(3aR) -Selitrectinib
A19252-10Selitrectinib 10mg
A19252-1Selitrectinib 1mg
S8636-5mgSelitrectinib (LOXO-195)
A19252-50Selitrectinib 50mg
A19252-25Selitrectinib 25mg
A19252-5Selitrectinib 5mg
A19252-10mM-DSelitrectinib 10mM * 1mL in DMSO

Popular Products